Bro 38 PE looks costly and also more than industry average. GMP is 70% any reason for such good gmp🤔 And will it sustain or fall, what's your thoughts?
Sir , it is a good IPO for listing gains but will wait for a good dip for long term, I personally will not purchase on PE above 32 , but will apply for listing gains.
Open : 3-Aug-2023 Close : 7-Aug-2023 Basis of Allotment : 10-Aug-2023 Initiation of Refunds: 11-Aug-2023 Credit of Shares : 14-Aug-2023 IPO Listing Date : 16-Aug-2023
@Palka You have to wait till the announcement of the price band to know the exact number of forms. If you assume 15000rs retail application, then sHNI will be 2440 forms and bHNI will be 4880 forms.
BTW , Late Mr.Rakesh Jhunjhunwalas's Rare enterprises is the 24.2% equity owner in Concord Biotech
Don't think SBFC will be delayed , Concord can hit nearby 20 Aug
15.2. KPCT| Link| Bookmark|
July 26, 2023 8:54:52 PM
Top Contributor (600+ Posts, 200+ Likes)
It is good thing, but during presence of r z two issue given nagative listing.....Metro shoes and policy bazar ..even nazara ki halat bhi bad me kharab ho gayi thi.... Let's hope this will not happen in Concord.
12.3. Aman Ipo| Link| Bookmark|
July 26, 2023 8:42:05 PM
Top Contributor (400+ Posts, 200+ Likes)
Itna bhav kis cheez ka kha rhe ho bhai btane ka. Agar aapko pta h to bta dijiye, nhi to ipo announce hone pe pta to chalna hi h. Ye to h nh ki aap nhi btaoge to hme kbhi pta hi nhi chalega.
Concord biotech will come in half the valuations of Divis Lab , I expect It to come at a PE of around 28 , so Some good scope for listing gain. It is an API company, and past 2 years for those companies hasn't been good , so LM will price the IPO reasonably
I know 37 PE is very high And FY 23 financials are posted , so no changes in PAT and valuations expected So it is confirm that PE will be 37 or more , if price band comes at 57 then PE will become around 40 .
Still premium is around 34-35 which is around 60%
The business is solid with excellent fundamentals and poised for high CAGR Growth. It is a listing gain and long term bet .
The Foreign investors have pressurized the company to target a Valuation of more than 650 mn $ , which comes at 5350 cr .